Choose   Change
BGI Advancing Genomics Together
BGI Advancing Research
BGI Advancing Drug Discovery
BGI Advancing Healthcare

BGI and British Columbia Organizations to Collaborate on Precision Medicine

BGI and five British Columbia-based biomedical and healthcare organizations have allied on personalized medicine. The Canadian partners include Providence Health Care, St. Paul's Foundation, the Vancouver Prostate Centre, Genome BC, and Deloitte. Together, the organizations will create "health centers of excellence" in Shenzen, China, where BGI is based, and Vancouver, British Columbia.
BGI exome promotion

Back-to-School Exome Promotion

FREE Bioinformatic Analysis FROM $499 | 100x Coverage | 10G Data Guaranteed. Do More With less - to celebrate the opening of the new academic year, BGI is introducing a unique opportunity get more bang for your buck with a limited-time exome promotion. Offer for a limited time only. Act Now!

Discover BGI’s Exome Sequencing Service

– 100 bp and 150bp Paired End sequencing options available
– Guaranteed ≥ 80% of bases with quality score of ≥Q30
– CAP compliant facility in Hong Kong
– US FDA 21 CFR Part 11 compliant processes

ASHG Conference

BGI Will Be Exhibiting At ASHG.

BGI will be exhibiting at the American Society of Human Genetics (ASHG) conference taking place in Vancouver, Canada, 18-22 October. We'll be at booth 323-325. Discover more about our wide range of sequencing services on the industry’s latest NGS platforms or come and speak to one of our knowledgeable staff members about your sequencing project.

Don’t hesitate to contact us to request a quote or to talk more about your requirements and how we can support your needs.

About BGI

BGI was founded in 1999 as a nonprofit research organization. Over the years, BGI has grown into a multinational genomics company with significant global operations and a wide variety of next generation sequencing (NGS) services including whole genome sequencingexome sequencing and RNA sequencing. With more than 5,000 employees across the globe and R&D, manufacturing, and commercial operations around the world, BGI is committed to providing genomics solutions to address the research, pharmaceutical, and clinical markets while utilizing the power of NGS technology in order to improve human health and empower large-scale human, plant, and animal genomics research.




On 5


With over 5000


Copyright © BGI 2016